A typical autosampler is a device connected to an analytical instrument and supplies periodic samples for analysis. Autosamplers facilitate significant productivity, precision, and accuracy increases in various analytical scenarios and are widely utilized in laboratories. Liquid injection, static and dynamic headspace, purge and capture, and fraction extraction are typical applications.
Various devices, including water analyzers, liquid and gas chromatography devices, and titrators, use autosamplers in various clinical and scientific applications. Autosamplers facilitate significant productivity, precision, and accuracy increases in various analytical scenarios and are widely utilized in laboratories.
The demand for autosamplers is increasing as biological and chemical research advances. The number of research studies and innovations is rising rapidly to satisfy the rising demand in industries such as life sciences, food and beverages, and chemicals. The conclusion of research in these industries is the laboratory testing and transfer of novel products to the manufacturing level.
According to a report by Research America, between 2013 and 2016, investments in medical health R&D increased by 20.6%. In 2016, the United States spent USD 171.8 billion on medical and health research and development. This R&D expenditure was supported by healthcare service companies, medical technology developers, and biopharmaceutical developers. Therefore, rising investments and expanding R&D-related activities are anticipated to fuel market expansion.
A limited number of specialty labs (primarily high-volume clinical or biomedical applications) are currently developing a concept known as total lab automation (TLA), which consists of specimen sorters, automation systems, robotic transporters, and analytical analyzers. These systems can have a significant effect on automating the testing and increasing the lab's productivity by eliminating the majority of manual tasks. These systems are utilized in numerous applications, including large-scale biorepositories, combinatorial chemistry, high-throughput screening, medical diagnostics, clinical and analytical testing, chemical and material processing, etc. Therefore, increasing laboratory automation creates opportunities for market expansion.
North America is the most significant global autosampler market shareholder and is estimated to exhibit a CAGR of 6.5% during the forecast period. This is related to the fact that many pharmaceutical and biopharmaceutical companies are involved in R&D. It is also anticipated that an increase in grants granted by governmental agencies, such as the National Institutes of Health (NIH) to support research efforts, will accelerate market expansion. It is projected that local enterprises' high caliber and demonstrated profitability will attract more research funding over the next few years.
In addition, the biopharmaceutical sector is among the biggest sources of funding for research. In order to generate interest in the products, many businesses are investing heavily in sample storage and the development of fresh, potential leads. The extensive spread of the coronavirus has also prompted a surge in the number of companies developing cures and vaccinations, which has helped the market grow.